Active

Contract Opportunity

THIS SOURCES SOUGHT IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES ONLY AND DOES NOT CONSTITUTE A SOLICITATION.
THE SUBMISSION OF PRICING, CAPABILITIES FOR PLANNING PURPOSES, AND OTHER MARKET INFORMATION IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI IN ACCORDANCE WITH (IAW) FAR 15.201(e).

This is not a solicitation announcement. This is a sources sought synopsis only. The purpose of this synopsis is to gain knowledge of potential qualified businesses under NAICS 325412. Responses to this synopsis will be used by the Government to make appropriate acquisition decisions. After review of the responses to this sources sought synopsis, a solicitation announcement may be published in the beta.SAM or GSA eBuy websites. Responses to this sources sought synopsis are not considered adequate responses to the solicitation announcement. All interested offerors will have to respond to the solicitation announcement in addition to responding to this sources sought announcement.

The Department of Veterans Affairs, Network 22 Contracts Office, is seeking sources for a base plus four option year contract in support of VA Albuquerque, New Mexico s requirement for radiopharmaceuticals. Specifically, the agency is seeking the following radiopharmaceuticals:

ITEM#
ITEM NAME
PRODUCT #
ESTIMATED QTY
BASE
OY1
OY2
OY3
OY4
0001
Tc99m MAG3 (Mertiatide) UD
102980
60

0002
Tc99m Sulfur Colloid UD
103003
100

0003
Tc99m MAA UD
102970
75

0004
Tc99m DMSA UD
102998
1

0005
I123 diagnostic caps (200uCi)
102338
100

0006
I123 MIBG UD
102367
1

0007
I131 diagnostic caps (up to 100uCi)
102372
4

0008
Ga67 10 mCi UD
102279
1

0009
I123 Whole body caps mCi
102338
1

0010
After hours pharmacist callout fee
198001
30

0011
In111 WBC blood kit
102408
2

0012
In111 Autologus WBC suspension
102408
2

0013
pyrophosphate (PYP) vial
102684
20

0014
Sincalide (CCK) vial
102767
5

0015
133 Xenon vials
103100
156

0016
I131 whole body diagnostic caps mCi
102372
4

0017
Tc99m DTPA aerosol vent UD
102990
1

0018
Tc99m Filtered sulfur Colloid
Â
1

0019
Tc99m heat damaged RBC
Â
1

0020
Tc99m DTPA renal UD
Â
10

0021
In111 DTPA UD
102400
1

0022
I131 therapy dose (per mCi)
102372
4

0023
Tc99m Choletec (Mebrofenin) UD
102974
150

0024
Cu64 Detectnet
Â
40

0025
Tc99m Lymphoseek (Tilmanocept)
Â
15

0026
Tc99m Sestamibi UD
Â
25

0027
Tc99m Tetrofosmin UD
Â
1600

0028
Tc99m NaTc04
Â
20

0029
Tc99m NaTc04 UD (1-10mCi)
Â
35

0030
Tl201 Thallious Chloride UD
Â
1

0031
Tc99m MDP (Medronate) UD
102977
55

0032
Ultra tag vial kit
Â
18

0033
Bicisate (Neurolite) UD
Â
1

0034
Ga68 Dotatate (Netspot)
Â
1

0035
Tc99m Hot Pyrophosphate (PYP)-amyloid
Â
5

0036
Pen Point Marker Co-57 100uCi
Â
3

0037
Flood source Co57 10mCi MED3709
Â
3

0038
Return kit MED 3709
Â
3

0039
Miscellaneous
Â
1


See attached Statement of Work for further information.

If you are interested, and capable of providing the required supplies please provide the requested information as indicated below. Responses to this notice should include: company name, address, point of contact, size of business pursuant to the following questions:

Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), Hubzone, Woman Owned Small Business (WOSB), Large Business, etc.)
Are you currently registered in SAM and VIP?
Is your company considered small under the NAICS code identified under this RFI? If not, is your company considered small under a related NAICS code?
Are you the manufacturer or distributor of the items being referenced above (or equivalent product/solution)? What is the manufacturing country of origin of these items?
If you re a small business and you are an authorized distributor/reseller for the items identified above (or equivalent product/solution), do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified?
Does your company have an FSS contract with GSA or the NAC or are you a contract holder with NASA SEWP or any other federal contract? If so, please provide the contract type and number.
If you are an FSS GSA/NAC or NASA SEWP contract holder or other federal contract holder, are the referenced items/solutions available on your schedule/contract?
Please provide general pricing for your products/solutions for market research purposes.
Please submit your capabilities in regards to the salient characteristics being provided and any information pertaining to brand name items to establish capabilities for planning purposes?
Identify any other companies owned (wholly or in-part) by the owners of this business who provide goods or services under the same or a related NAICS codes.
Identify any other companies owned (wholly or in-part) by the owners of this business who provide goods or services that are registered under the same or a related NAICS code with the Center for Veterans Enterprise (CVE); Provide the certification type (SDVOSB/VOSB), Federal Identification Number, and state of incorporation for each.
Do you plan on responding to a solicitation for this requirement with a Joint Venture utilizing multiple owned companies as majority or non-majority owner?
Yes ___No ___ If yes, please identify which companies are considering a Joint Venture and the ownership of each company.
Are these products manufactured in the United States? If not, where are they manufactured?

Responses to this notice shall be submitted via email to Adrienne.brown4@va.gov. Telephone responses shall not be accepted. Responses must be received no later than Friday, February 9, 2024 at 9:00 AM PST. Include *SUBJECT of sources sought in the subject line of responses. If a solicitation is issued it shall be announced at a later date, and all interested parties must respond to that solicitation announcement separately from the responses to this request for information. Responses to this notice are not a request to be added to a prospective bidders list or to receive a copy of the solicitation.

Attachments/Links